S.M. Daluge
Glaxo Wellcome Inc.
Research Triangle Park
North Carolina 27709
USA
Name/email consistency: high
- 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity. Daluge, S.M., Good, S.S., Faletto, M.B., Miller, W.H., St Clair, M.H., Boone, L.R., Tisdale, M., Parry, N.R., Reardon, J.E., Dornsife, R.E., Averett, D.R., Krenitsky, T.A. Antimicrob. Agents Chemother. (1997)